| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.895 | 0 | 0.895 | Angiotensin AT1 receptor antagonist | 0.602 0.001 CID_101944494 0.79 0 CID_11676932 0.626 0.001 CID_154700101 0.112 0.002 CID_154699620 | ||
| 0.893 | 0 | 0.893 | Angiotensin II receptor antagonist | 0.622 0.001 CID_101944494 0.806 0 CID_11676932 0.639 0.001 CID_154700101 0.142 0.002 CID_154699620 | ||
| 0.882 | 0.001 | 0.882 | Angiotensin AT1A receptor antagonist | 0.689 0.001 CID_101944494 0.792 0.001 CID_11676932 0.662 0.001 CID_154700101 0.063 0.003 CID_154699620 | ||
| 0.876 | 0 | 0.876 | Angiotensin AT1B receptor antagonist | 0.465 0.001 CID_101944494 0.807 0 CID_11676932 0.395 0.001 CID_154700101 0.025 0.004 CID_154699620 | ||
| 0.777 | 0.001 | 0.777 | Angiotensin AT2 receptor antagonist | 0.512 0.002 CID_101944494 0.639 0.001 CID_11676932 0.477 0.002 CID_154700101 0.09 0.004 CID_154699620 | ||
| 0.538 | 0.022 | 0.538 | 5 Hydroxytryptamine release inhibitor | 0.447 0.053 CID_101944494 0.47 0.043 CID_11676932 0.484 0.038 CID_154700101 | ||
| 0.449 | 0.002 | 0.449 | Phosphodiesterase 7B inhibitor | 0.402 0.003 CID_101944494 0.421 0.002 CID_11676932 0.411 0.003 CID_154700101 | ||
| 0.462 | 0.044 | 0.512 | Histamine release inhibitor | 0.43 0.06 CID_101944494 0.512 0.025 CID_11676932 0.509 0.026 CID_154700101 | CID_11676932 | |
| 0.272 | 0.005 | 0.272 | Phosphodiesterase 3A inhibitor | 0.213 0.007 CID_101944494 0.212 0.007 CID_11676932 0.196 0.009 CID_154700101 | ||
| 0.258 | 0.003 | 0.258 | Phosphodiesterase 1A inhibitor | 0.115 0.008 CID_101944494 0.102 0.009 CID_11676932 0.077 0.018 CID_154700101 | ||
| 0.249 | 0.011 | 0.313 | Catenin beta inhibitor | 0.212 0.024 CID_101944494 0.313 0.005 CID_11676932 0.232 0.015 CID_154700101 | CID_11676932 | |
| 0.254 | 0.042 | 0.361 | Growth hormone agonist | 0.29 0.034 CID_101944494 0.361 0.021 CID_11676932 0.222 0.051 CID_154700101 0.166 0.075 CID_154699620 | CID_11676932 | |
| 0.21 | 0.009 | 0.21 | Phosphodiesterase I inhibitor | 0.109 0.035 CID_101944494 0.106 0.038 CID_11676932 0.094 0.052 CID_154700101 | ||
| 0.191 | 0.012 | 0.191 | Phosphodiesterase 4D inhibitor | 0.171 0.015 CID_101944494 0.145 0.02 CID_11676932 0.117 0.03 CID_154700101 | ||
| 0.182 | 0.008 | 0.228 | Peroxisome proliferator-activated receptor gamma agonist | 0.15 0.013 CID_101944494 0.228 0.005 CID_11676932 0.189 0.007 CID_154700101 | CID_11676932 | |
| 0.171 | 0.005 | 0.171 | Phosphodiesterase 1B inhibitor | 0.071 0.03 CID_101944494 0.066 0.035 CID_11676932 | ||
| 0.169 | 0.004 | 0.211 | Leukotriene D4 antagonist | 0.118 0.005 CID_101944494 0.211 0.004 CID_11676932 0.112 0.005 CID_154700101 | CID_11676932 | |
| 0.175 | 0.015 | 0.306 | Alcohol dehydrogenase inhibitor | 0.12 0.034 CID_101944494 0.306 0.005 CID_11676932 0.26 0.007 CID_154700101 | CID_11676932 | |
| 0.156 | 0.004 | 0.156 | Phosphodiesterase 1C inhibitor | 0.079 0.02 CID_101944494 0.08 0.02 CID_11676932 0.065 0.038 CID_154700101 | ||
| 0.155 | 0.005 | 0.155 | Fatty acid synthase inhibitor | 0.109 0.009 CID_101944494 0.091 0.014 CID_11676932 0.062 0.033 CID_154700101 | ||
| 0.154 | 0.005 | 0.154 | Glutamate (mGluR group II) agonist | 0.116 0.005 CID_101944494 0.144 0.005 CID_11676932 0.109 0.006 CID_154700101 | ||
| 0.147 | 0.004 | 0.147 | Glutamate (mGluR2) agonist | 0.109 0.005 CID_101944494 0.13 0.005 CID_11676932 0.103 0.006 CID_154700101 | ||
| 0.23 | 0.096 | 0.267 | Cardiotonic | 0.239 0.09 CID_101944494 0.192 0.126 CID_11676932 0.267 0.072 CID_154700101 | CID_154700101 | |
| 0.129 | 0.005 | 0.129 | Bombesin 3 receptor antagonist | 0.103 0.011 CID_101944494 0.106 0.01 CID_11676932 0.109 0.009 CID_154700101 | ||
| 0.127 | 0.005 | 0.127 | Phosphodiesterase VII inhibitor | 0.111 0.008 CID_101944494 0.112 0.008 CID_11676932 0.106 0.01 CID_154700101 | ||
| 0.127 | 0.01 | 0.127 | Phosphodiesterase 4C inhibitor | 0.104 0.014 CID_101944494 0.072 0.025 CID_11676932 0.065 0.03 CID_154700101 | ||
| 0.135 | 0.022 | 0.175 | Glutamate receptor agonist | 0.175 0.014 CID_11676932 | CID_11676932 | |
| 0.116 | 0.019 | 0.116 | Glutamate (mGluR) agonist | 0.063 0.042 CID_101944494 0.106 0.022 CID_11676932 0.061 0.044 CID_154700101 | ||
| 0.099 | 0.005 | 0.099 | Nicotinic acid receptor 2 agonist | 0.057 0.012 CID_101944494 0.085 0.007 CID_11676932 0.061 0.011 CID_154700101 | ||
| 0.098 | 0.008 | 0.123 | Sphingosine kinase 2 inhibitor | 0.123 0.005 CID_101944494 0.072 0.02 CID_154700101 | CID_101944494 | |
| 0.089 | 0.005 | 0.097 | Glutamate (mGluR group II) antagonist | 0.083 0.006 CID_101944494 0.097 0.005 CID_11676932 0.051 0.015 CID_154700101 | CID_11676932 | |
| 0.09 | 0.009 | 0.09 | Kinesin-like protein 1 inhibitor | 0.04 0.022 CID_101944494 0.057 0.014 CID_11676932 0.057 0.014 CID_154700101 0.035 0.028 CID_154699620 | ||
| 0.09 | 0.009 | 0.09 | Kinesin antagonist | 0.04 0.022 CID_101944494 0.057 0.014 CID_11676932 0.057 0.014 CID_154700101 0.035 0.028 CID_154699620 | ||
| 0.085 | 0.006 | 0.099 | AMPA 2 receptor antagonist | 0.051 0.011 CID_101944494 0.099 0.005 CID_11676932 0.048 0.011 CID_154700101 | CID_11676932 | |
| 0.099 | 0.023 | 0.099 | Phosphodiesterase III inhibitor | 0.073 0.041 CID_101944494 0.091 0.027 CID_11676932 0.089 0.028 CID_154700101 | ||
| 0.072 | 0.005 | 0.072 | Glutamate (mGluR2) antagonist | 0.059 0.006 CID_101944494 0.06 0.006 CID_11676932 0.036 0.014 CID_154700101 | ||
| 0.131 | 0.07 | 0.131 | NADPH oxidase inhibitor | 0.107 0.101 CID_11676932 | ||
| 0.076 | 0.019 | 0.097 | Sphingosine kinase inhibitor | 0.097 0.008 CID_101944494 0.065 0.031 CID_154700101 | CID_101944494 | |
| 0.084 | 0.028 | 0.084 | Phosphodiesterase VIII inhibitor | 0.072 0.048 CID_101944494 0.071 0.051 CID_11676932 0.072 0.05 CID_154700101 | ||
| 0.051 | 0.01 | 0.067 | Endothelin receptor antagonist | 0.027 0.02 CID_101944494 0.067 0.008 CID_11676932 0.031 0.017 CID_154700101 | CID_11676932 | |
| 0.118 | 0.08 | 0.118 | Acetylcholinesterase inhibitor | |||
| 0.057 | 0.02 | 0.057 | Phosphodiesterase 3B inhibitor | 0.045 0.03 CID_101944494 0.055 0.022 CID_11676932 0.05 0.025 CID_154700101 | ||
| 0.05 | 0.015 | 0.064 | AMPA 4 receptor antagonist | 0.064 0.009 CID_11676932 | CID_11676932 | |
| 0.058 | 0.026 | 0.058 | Carbonic anhydrase II stimulant | 0.047 0.046 CID_101944494 0.058 0.025 CID_11676932 0.047 0.046 CID_154700101 | ||
| 0.046 | 0.017 | 0.06 | Glucagon-like peptide 1 receptor antagonist | 0.06 0.008 CID_11676932 0.045 0.019 CID_154700101 | CID_11676932 | |
| 0.045 | 0.017 | 0.045 | Nicotinic acid receptor agonist | 0.036 0.025 CID_11676932 | ||
| 0.057 | 0.031 | 0.058 | Autotaxin inhibitor | 0.054 0.034 CID_101944494 0.058 0.03 CID_11676932 | CID_11676932 | |
| 0.05 | 0.025 | 0.121 | NMDA receptor subunit 3B antagonist | 0.121 0.009 CID_11676932 | CID_11676932 | |
| 0.057 | 0.038 | 0.069 | Leukotriene C antagonist | 0.069 0.014 CID_11676932 | CID_11676932 | |
| 0.029 | 0.014 | 0.033 | Kainate receptor 4 antagonist | 0.033 0.012 CID_11676932 | CID_11676932 | |
| 0.039 | 0.025 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 CID_11676932 | CID_11676932 | |
| 0.035 | 0.021 | 0.035 | Growth hormone releasing factor agonist | 0.029 0.027 CID_154699620 | ||
| 0.065 | 0.056 | 0.065 | Cannabinoid receptor antagonist | |||
| 0.029 | 0.021 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 CID_11676932 | CID_11676932 | |
| 0.101 | 0.095 | 0.114 | Glutamate receptor antagonist | 0.114 0.08 CID_11676932 0.103 0.093 CID_154700101 | CID_11676932 | |
| 0.057 | 0.051 | 0.11 | Prostaglandin F2 alpha antagonist | 0.067 0.035 CID_101944494 0.094 0.014 CID_11676932 0.11 0.009 CID_154700101 | CID_154700101 | |
| 0.022 | 0.016 | 0.022 | Bombesin agonist | |||
| 0.053 | 0.048 | 0.053 | CXC chemokine 4 receptor antagonist | |||
| 0.044 | 0.04 | 0.044 | Phosphodiesterase 4A inhibitor | |||
| 0.018 | 0.014 | 0.018 | Bombesin 3 receptor agonist | |||
| 0.058 | 0.054 | 0.102 | Leukotriene antagonist | 0.102 0.021 CID_11676932 0.058 0.054 CID_154700101 | CID_11676932 | |
| 0.02 | 0.016 | 0.025 | Endothelin A receptor antagonist | 0.025 0.012 CID_11676932 | CID_11676932 | |
| 0.034 | 0.03 | 0.089 | NMDA receptor subunit 3A antagonist | 0.089 0.01 CID_11676932 | CID_11676932 | |
| 0.017 | 0.015 | 0.017 | Growth hormone release promoting | |||
| 0.036 | 0.037 | 0.046 | Leukotriene C4 antagonist | 0.046 0.014 CID_11676932 | CID_11676932 | |
| 0.016 | 0.02 | 0.021 | Kainate receptor 5 antagonist | 0.021 0.014 CID_11676932 | CID_11676932 | |
| 0.018 | 0.022 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 CID_11676932 | CID_11676932 | |
| 0.014 | 0.018 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.013 CID_11676932 | CID_11676932 | |
| 0.037 | 0.046 | 0.071 | Glutamate (mGluR4) antagonist | 0.071 0.01 CID_11676932 | CID_11676932 | |
| 0.011 | 0.026 | 0.029 | Kainate receptor 1 antagonist | 0.029 0.011 CID_11676932 | CID_11676932 | |
| 0.11 | 0.124 | 0.179 | Cholinergic | 0.179 0.057 CID_154699620 | CID_154699620 | |
| 0.05 | 0.068 | 0.097 | Sphingosine 1-phosphate receptor 4 agonist | 0.097 0.026 CID_11676932 | CID_11676932 | |
| 0.045 | 0.066 | 0.067 | Sphingosine 1-phosphate receptor 5 agonist | 0.067 0.018 CID_11676932 | CID_11676932 | |
| 0.015 | 0.036 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.019 CID_11676932 | CID_11676932 | |
| 0.016 | 0.041 | 0.041 | Prostaglandin EP4 antagonist | 0.041 0.01 CID_11676932 | CID_11676932 | |
| 0.015 | 0.041 | 0.032 | Leukotriene B4 receptor 1 antagonist | 0.032 0.017 CID_11676932 0.029 0.019 CID_154699620 | CID_11676932 | |
| 0.035 | 0.063 | 0.054 | Glutamate (mGluR group III) antagonist | 0.054 0.017 CID_11676932 | CID_11676932 | |
| 0.022 | 0.056 | 0.044 | Kainate receptor antagonist | 0.044 0.025 CID_11676932 | CID_11676932 | |
| 0.034 | 0.093 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 CID_11676932 | CID_11676932 | |
| 0.026 | 0.112 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.044 CID_11676932 | CID_11676932 | |
| 0.096 | 0.183 | 0.125 | Hemostatic | 0.125 0.104 CID_11676932 | CID_11676932 | |
| 0.022 | 0.125 | 0.04 | Glutamate (mGluR8) antagonist | 0.034 0.03 CID_11676932 0.04 0.017 CID_154699620 | CID_154699620 | |
| 0.015 | 0.166 | 0.065 | Prostaglandin antagonist | 0.065 0.029 CID_11676932 | CID_11676932 | |
| 0.085 | 0.242 | 0.223 | Hypolipemic | 0.15 0.136 CID_101944494 0.223 0.081 CID_154700101 | CID_154700101 | |
| 0.004 | 0.219 | 0.032 | Purinergic P2T antagonist | 0.032 0.012 CID_154699620 | CID_154699620 | |
| 0.014 | 0.351 | 0.077 | Leukotriene synthesis inhibitor | 0.077 0.039 CID_154699620 | CID_154699620 | |
| 0.1 | 0.477 | 0.264 | Cyclophilin D inhibitor | 0.249 0.214 CID_101944494 0.264 0.197 CID_11676932 0.247 0.217 CID_154700101 | CID_11676932 | |
| 0.079 | 0.466 | 0.249 | Sodium/bile acid cotransporter inhibitor | 0.249 0.129 CID_101944494 0.198 0.191 CID_11676932 | CID_101944494 | |
| 0.095 | 0.505 | 0.217 | Interleukin 2 agonist | 0.217 0.161 CID_101944494 0.212 0.169 CID_154699620 | CID_101944494 | |
| 0.004 | 0.48 | 0.048 | 1,3-Beta-glucan synthase inhibitor | 0.048 0.003 CID_154699620 | CID_154699620 | |
| 0.048 | 0.629 | 0.258 | MAP kinase kinase 4 inhibitor | 0.258 0.005 CID_154699620 | CID_154699620 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |